In the COVID-19 patients, the IgM antibodies against the S RBD of the Wuhan strain and the Alpha and Delta variants significantly increased on day 14 after disease onset (compared to day 0, all P < 0.001) and subsequently declined on day 28 after enrollment (Fig. 1A). Here, CD40LG is linked to COVID-19.